An Epidemiological Study to Investigate the Characteristics of RSV Infection in Adult Hematopoietic Cell Transplant Recipients or Hematological Malignancies Patients in Tianjin HI (Hematology Institute)

RecruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

June 20, 2025

Study Completion Date

June 20, 2025

Conditions

RSV Infection

Interventions

OTHER

RSV infection observation cohort

No intervention; Epidemiological Study. Participants will receive standard care based on local clinical practice

Trial Locations (1)

RECRUITING

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin

All Listed Sponsors

lead

Institute of Hematology & Blood Diseases Hospital, China

OTHER